NCT01210157 Galectin-3 Binding Protein in Cardiovascular Disease and Chronic Heart Failure Status COMPLETED Phase N/A
NCT01207167 Mediators of Atherosclerosis in South Asians Living in America Status ACTIVE_NOT_RECRUITING Phase N/A
NCT01205594 IRB-HSR# 14296 The Use of the Intrathoracic Pressure Regulator (ITPR) to Improve Systemic Blood Pressure in Patient Undergoing CABG Surgery Status COMPLETED Phase PHASE2
NCT01201369 A Study to Examine the Implantation Characteristics of Two Drug-Eluting Stents Status COMPLETED Phase NA
NCT01200693 Z-SEA-SIDE: Sirolimus Versus Everolimus Versus Zotarolimus-eluting Stent Assessment in Bifurcated Lesions and Clinical SIgnificance of Residual siDE-branch Stenosis Status COMPLETED Phase PHASE4
NCT01198405 Study of Enahnced External Counterpulsation to Treat Coronary Heart Disease Status UNKNOWN Phase NA
NCT01196819 Randomized MicroPort's Firehawk DES Versus Xience V: TARGET I Trial Status COMPLETED Phase NA
NCT01192724 Additional Benefit of Cilostazol to Dual Antiplatelet Therapy After Biolimus-eluting Stent Implantation Status COMPLETED Phase PHASE4
NCT01190904 Hormones and Sexual Function Predict Outcomes in Revascularized Men With Diabetes Status COMPLETED Phase N/A
NCT01190579 Dual Source CT Angiography for Detection of Coronary Artery Stenoses Status UNKNOWN Phase N/A
NCT01190072 Lipid-lowering Therapy for Secondary Prevention in Patients Undergoing Elective Percutaneous Coronary Intervention (PCI) Status TERMINATED Phase N/A
NCT01187992 Full-dose Atorvastatin After Acute Coronary Syndrome (ACS) in Non-revascularisable Coronary Artery Disease Status TERMINATED Phase PHASE3
NCT01186666 Imaging and Biomarkers of Atherosclerosis in Patients With Stable or Unstable Coronary Artery Disease Status COMPLETED Phase NA
NCT01186146 Duration of Clopidogrel Therapy After Drug-Eluting Stent (DES-LATE) Status COMPLETED Phase PHASE4